Inventor · disambiguated record
Gabriele Matschiner
Also filed as: MATSCHINER GABRIELE
21 granted patents·9 pending applications·159 citations·filing 2005–2022
95Inventor score
Files withPIERIS PHARMACEUTICALS GMBH15ASTRAZENECA AB3MATSCHINER GABRIELE3PIERIS AG3DAIICHI SANKYO CO LTD2
Top patents by PatentIndex Score
30 records- 0194US9260492B2Muteins of human lipocalin 2 with affinity for glypican-3 (GPC-3)MATSCHINER GABRIELE·Filed 2011·Granted Feb 16, 2016·27 cites·18 claims
- 0291US10618941B2Muteins of human lipocalin 2 (Lcn2,hNGAL) with affinity for a given targetPIERIS PHARMACEUTICALS GMBH·Filed 2016·Granted Apr 14, 2020·6 cites·20 claims
- 0390US9549968B2Muteins of human lipocalin 2 (LcnC,hNGAL) with affinity for a given targetSKERRA ARNE·Filed 2010·Granted Jan 24, 2017·21 cites·37 claims
- 0490US9051382B2Human neutrophil gelatinase-associated lipocalin (hNGAL) muteins that bind hepcidin and nucleic acid encoding suchTRENTMANN STEFAN·Filed 2011·Granted Jun 9, 2015·26 cites·13 claims
- 0589US10273275B2Muteins of human lipocalin 2 with affinity for glypican-3 (GPC3) and methods of use thereofPIERIS PHARMACEUTICALS GMBH·Filed 2016·Granted Apr 30, 2019·10 cites·20 claims
- 0688US7892827B2Compound with affinity for the cytotoxic T lymphocyte-associated antigen (CTLA-4)PIERIS AG·Filed 2005·Granted Feb 22, 2011·21 cites·18 claims
- 0787US10898545B2Tear lipocalin muteins binding IL-4 r alphaASTRAZENECA AB·Filed 2019·Granted Jan 26, 2021·2 cites·15 claims
- 0887US10526384B2Interleukin-17A-specific and interleukin-23-specific binding polypeptides and uses thereofPIERIS PHARMACEUTICALS GMBH·Filed 2013·Granted Jan 7, 2020·5 cites·16 claims
- 0987US9687524B2Tear lipocalin muteins binding IL-4 R alphaPIERIS PHARMACEUTICALS GMBH·Filed 2015·Granted Jun 27, 2017·6 cites·7 claims
- 1086US9221885B2Muteins of human lipocalin 2 with affinity for CTLA-4MATSCHINER GABRIELE·Filed 2011·Granted Dec 29, 2015·6 cites·18 claims
- 1185US8986951B2Tear lipocalin in muteins binding IL-4 R alphaHOHLBAUM ANDREAS·Filed 2011·Granted Mar 24, 2015·13 cites·21 claims
- 1283US10232014B2Tear lipocalin muteins binding IL-4 R alphaPIERIS PHARMACEUTICALS GMBH·Filed 2017·Granted Mar 19, 2019·3 cites·25 claims
- 1383US9212208B2Muteins with tear lipocalin having affinity to human c-Met receptor tyrosine kinase and methods for obtaining the sameMATSCHINER GABRIELE·Filed 2009·Granted Dec 15, 2015·6 cites·22 claims
- 1482US10400016B2Proteins specific for calcitonin gene-related peptidePIERIS PHARMACEUTICALS GMBH·Filed 2016·Granted Sep 3, 2019·4 cites·25 claims
- 1575US11034737B2Proteins specific for calcitonin gene-related peptidePIERIS PHARMACEUTICALS GMBH·Filed 2019·Granted Jun 15, 2021·1 cites·17 claims
- 1672US2021196788A1Tear lipocalin muteins binding il-4 r alphaASTRAZENECA AB·Filed 2020·Application pending·0 cites
- 1769US9150629B2Human tear lipocalins which bind PCSK9 and methods of use thereofPIERIS AG·Filed 2014·Granted Oct 6, 2015·1 cites·56 claims
- 1866US10927154B2Multi-specific polypeptide useful for localized tumor immunomodulationPIERIS PHARMACEUTICALS GMBH·Filed 2015·Granted Feb 23, 2021·1 cites·6 claims
- 1964US11827681B2Muteins of human lipocalin 2 (Lcn2, hNGAL) with affinity for a given targetPIERIS PHARMACEUTICALS GMBH·Filed 2020·Granted Nov 28, 2023·0 cites·21 claims
- 2060US10787491B2Nucleic acid molecules encoding muteins of human lipocalin 2 with affinity for glypican-3 (GPC3)PIERIS PHARMACEUTICALS GMBH·Filed 2019·Granted Sep 29, 2020·0 cites·11 claims
- 2160US2020148733A1Novel interleukin-17a-specific and interleukin-23-specific binding polypeptides and uses thereofPIERIS PHARMACEUTICALS GMBH·Filed 2019·Application pending·0 cites
- 2256US2009274623A1In vivo imaging agents for met receptor tyrosine kinaseGEN ELECTRIC·Filed 2008·Application pending·0 cites
- 2352US2017369542A1Human neutrophil gelatinase-associated lipocalin (hngal) muteins that bind hepcidin and nucleic acid encoding suchPIERIS PHARMACEUTICALS GMBH·Filed 2017·Application pending·0 cites
- 2451US2024228562A1Novel lipocalin muteins specific for connective tissue growth factor (ctgf)PIERIS PHARMACEUTICALS GMBH·Filed 2022·Application pending·0 cites
- 2550US9598476B2Nucleic acid molecules encoding muteins of human tear lipocalin which bind PCSK9DAIICHI SANKYO CO LTD·Filed 2015·Granted Mar 21, 2017·0 cites·51 claims
- 2650US2017173112A1Novel binding proteins for pcsk9DAIICHI SANKYO CO LTD·Filed 2017·Application pending·0 cites
- 2749US9751920B2Muteins with tear lipocalin having affinity to human c-met receptor tyrosine kinase and methods for obtaining the samePIERIS PHARMACEUTICALS GMBH·Filed 2015·Granted Sep 5, 2017·0 cites·2 claims
- 2846US2015291675A1Human neutrophil gelatinase-associated lipocalin (hngal) muteins that bind hepcidin and nucleic acid encoding suchPIERIS AG·Filed 2015·Application pending·0 cites
- 2943US2022168387A1Inhaled administration of lipocalin muteinsPIERIS PHARMACEUTICALS GMBH·Filed 2020·Application pending·0 cites
- 3042US2022193191A1Lipocalin mutein for treatment of asthmaASTRAZENECA AB·Filed 2020·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →